camptothecin has been researched along with gastrins in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bearss, D; Von Hoff, DD | 1 |
Owlia, A; Singh, P; Wu, H | 1 |
Rengifo-Cam, W; Sarkar, S; Singh, AP; Singh, P; Umar, S; Wood, TG | 1 |
Bayraktar, S; Broome, P; de Queiroz Marques Junior, E; Leslie, M; Nowacki, M; Rocha-Lima, CM; Susnerwala, S; Weissman, C | 1 |
Guo, H; Han, K; Tang, H; Yan, Y; Zhang, J; Zhang, L; Zhang, X; Zhuang, K | 1 |
1 review(s) available for camptothecin and gastrins
Article | Year |
---|---|
New drugs for patients with pancreatic cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cancer Vaccines; Capecitabine; Deoxycytidine; Diphtheria Toxoid; Fluorouracil; Gastrins; History, 16th Century; Humans; Palliative Care; Pancreatic Neoplasms; Prognosis; Randomized Controlled Trials as Topic | 2002 |
1 trial(s) available for camptothecin and gastrins
Article | Year |
---|---|
A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cancer Vaccines; Colorectal Neoplasms; Diarrhea; Drug Administration Schedule; Female; Gastrins; Humans; Infusions, Intravenous; Injections, Intramuscular; Irinotecan; Male; Middle Aged; Nausea; Neutropenia; Treatment Outcome; Vomiting | 2014 |
3 other study(ies) available for camptothecin and gastrins
Article | Year |
---|---|
Precursor peptide progastrin(1-80) reduces apoptosis of intestinal epithelial cells and upregulates cytochrome c oxidase Vb levels and synthesis of ATP.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Caspase 3; Caspase 9; Caspases; Cell Line; Colonic Neoplasms; Electron Transport Complex IV; Enzyme Activation; Gastrins; Intestinal Mucosa; Mitochondria; Promoter Regions, Genetic; Protein Precursors; Rats; RNA, Messenger; Up-Regulation | 2003 |
Insulin-like growth factors are more effective than progastrin in reversing proapoptotic effects of curcumin: critical role of p38MAPK.
Topics: Animals; Antibodies; Apoptosis; Autocrine Communication; Caco-2 Cells; Camptothecin; Caspase 3; Caspase 9; Cell Line; Cell Proliferation; CSK Tyrosine-Protein Kinase; Curcumin; Epithelial Cells; Gastrins; Humans; I-kappa B Kinase; Ileum; Imidazoles; Insulin-Like Growth Factor II; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Protein Precursors; Protein-Tyrosine Kinases; Pyridines; Rats; Somatomedins; src-Family Kinases; Transcription Factor RelA; Transfection | 2010 |
Gastrin induces multidrug resistance via the degradation of p27Kip1 in the gastric carcinoma cell line SGC7901.
Topics: Aged; Camptothecin; Carcinoma; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p27; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorouracil; Gastrins; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Phosphorylation; Proteolysis; RNA, Small Interfering; S-Phase Kinase-Associated Proteins; Stomach Neoplasms | 2017 |